-
Signature
-
/s/ Adam N. King, Attorney-in-Fact
-
Stock symbol
-
IPGP
-
Transactions as of
-
Jan 29, 2024
-
Transactions value $
-
-$51,700
-
Form type
-
4
-
Date filed
-
1/31/2024, 04:08 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
IPGP |
Common Stock |
Options Exercise |
$51.5K |
+813 |
+4.93% |
$63.40 |
17.3K |
Jan 29, 2024 |
Direct |
|
transaction |
IPGP |
Common Stock |
Sale |
-$64.6K |
-657 |
-3.8% |
$98.36 |
16.6K |
Jan 29, 2024 |
Direct |
F1, F2 |
transaction |
IPGP |
Common Stock |
Sale |
-$15.6K |
-156 |
-0.94% |
$100.00 |
16.5K |
Jan 29, 2024 |
Direct |
F1, F3 |
transaction |
IPGP |
Common Stock |
Options Exercise |
$39.9K |
+629 |
+3.81% |
$63.40 |
17.1K |
Jan 30, 2024 |
Direct |
|
transaction |
IPGP |
Common Stock |
Sale |
-$62.9K |
-629 |
-3.67% |
$100.00 |
16.5K |
Jan 30, 2024 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
IPGP |
Director Stock Option (right to buy) |
Options Exercise |
$0 |
-813 |
-21.39% |
$0.00 |
2.99K |
Jan 29, 2024 |
Common Stock |
813 |
$63.40 |
Direct |
F4 |
transaction |
IPGP |
Director Stock Option (right to buy) |
Options Exercise |
$0 |
-629 |
-21.06% |
$0.00 |
2.36K |
Jan 30, 2024 |
Common Stock |
629 |
$63.40 |
Direct |
F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: